Cullinan Oncology (CGEM) News Today → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free CGEM Stock Alerts $28.00 +0.28 (+1.01%) (As of 01:22 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJennifer Michaelson Sells 58,000 Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM) Stockinsidertrades.com - May 9 at 8:49 AMInsider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson ...finance.yahoo.com - May 9 at 6:38 AMCullinan Oncology, Inc. (NASDAQ:CGEM) Insider Sells $1,628,060.00 in Stockmarketbeat.com - May 8 at 9:21 PMCullinan Oncology (NASDAQ:CGEM) Sets New 12-Month High at $29.25americanbankingnews.com - May 5 at 2:06 AMCullinan Oncology (NASDAQ:CGEM) Reaches New 1-Year High at $29.25marketbeat.com - May 3 at 8:31 PMStifel Nicolaus Initiates Coverage on Cullinan Oncology (NASDAQ:CGEM)americanbankingnews.com - May 3 at 5:50 AMBuy Rating Justified: Cullinan Management’s Promising TCE Therapy Paves the Way for Market Dominancemarkets.businessinsider.com - May 1 at 5:47 PMStifel Initiates Coverage of Cullinan Therapeutics (CGEM) with Buy Recommendationmsn.com - May 1 at 5:47 PMCullinan Oncology (NASDAQ:CGEM) Now Covered by Analysts at Stifel Nicolausmarketbeat.com - May 1 at 7:16 AMCullinan Oncology (NASDAQ:CGEM) Sees Unusually-High Trading Volumemarketbeat.com - April 29 at 2:32 PMCullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officerglobenewswire.com - April 29 at 7:00 AMCullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Growth in Short Interestamericanbankingnews.com - April 29 at 3:44 AMCullinan Oncology (NASDAQ:CGEM) Reaches New 1-Year High at $21.89marketbeat.com - April 26 at 2:35 PMWhy Is Cullinan Therapeutics Stock Trading Higher On Wednesday?finance.yahoo.com - April 24 at 7:48 PMCullinan Oncology (NASDAQ:CGEM) Trading Up 7.8%marketbeat.com - April 24 at 6:15 PMCullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024globenewswire.com - April 24 at 10:09 AMCullinan Oncology (NASDAQ:CGEM) Trading Down 3.3%marketbeat.com - April 19 at 1:59 PMQ2 2024 EPS Estimates for Cullinan Oncology, Inc. (NASDAQ:CGEM) Raised by Analystmarketbeat.com - April 19 at 8:32 AMCullinan Oncology (NASDAQ:CGEM) Stock Price Up 5.9% After Analyst Upgrademarketbeat.com - April 18 at 10:35 AMJonestrading Boosts Cullinan Oncology (NASDAQ:CGEM) Price Target to $26.00marketbeat.com - April 18 at 8:29 AMHC Wainwright Weighs in on Cullinan Oncology, Inc.'s Q2 2024 Earnings (NASDAQ:CGEM)marketbeat.com - April 18 at 5:59 AMWilliam Blair Comments on Cullinan Oncology, Inc.'s Q1 2024 Earnings (NASDAQ:CGEM)marketbeat.com - April 17 at 4:48 PMCullinan Oncology, Inc. (NASDAQ:CGEM) Receives Average Rating of "Buy" from Brokeragesmarketbeat.com - April 17 at 4:26 PMCullinan Oncology (NASDAQ:CGEM) PT Raised to $30.00marketbeat.com - April 17 at 3:45 PMCullinan Oncology (NASDAQ:CGEM) Shares Gap Up to $17.32marketbeat.com - April 17 at 10:51 AMCullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseasesfinanznachrichten.de - April 17 at 10:19 AMBuy Recommendation: Cullinan Management’s Strategic Position in Autoimmune Disease Market with Promising CLN-978 Therapymarkets.businessinsider.com - April 16 at 11:58 PMCullinan rebrands with $280M private offering, pivot away from cancerbizjournals.com - April 16 at 6:57 PMCullinan changes name, pivots to autoimmune diseasefinance.yahoo.com - April 16 at 1:57 PMCullinan To Expand Into Autoimmune Diseases, Privately Places $280 Mln; Stock Up In Pre-Marketmarkets.businessinsider.com - April 16 at 1:57 PMCullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equitymarkets.businessinsider.com - April 16 at 1:57 PMCullinan Oncology (NASDAQ:CGEM) Price Target Lowered to $29.00 at HC Wainwrightmarketbeat.com - April 16 at 1:28 PMCullinan Oncology (NASDAQ:CGEM) Hits New 52-Week High at $20.62marketbeat.com - April 16 at 11:02 AMCullinan Oncology Shares Jump 21% on Planned Autoimmune Diseases Expansion, Private Placementmarketwatch.com - April 16 at 8:56 AMWilliam Blair Initiates Coverage of Cullinan Oncology (CGEM) with Outperform Recommendationmsn.com - April 16 at 8:56 AMCullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseasesglobenewswire.com - April 16 at 7:00 AMCullinan Therapeutics Announces Oversubscribed $280 million Private Placementglobenewswire.com - April 16 at 6:59 AMCullinan Oncology (NASDAQ:CGEM) Coverage Initiated at William Blairmarketbeat.com - April 15 at 8:35 AMCullinan Oncology, Inc. (NASDAQ:CGEM) Short Interest Up 53.9% in Marchmarketbeat.com - April 12 at 8:36 PMCullinan Oncology (NASDAQ:CGEM) Shares Gap Down to $17.02marketbeat.com - April 8 at 11:37 AMCullinan Oncology (NASDAQ:CGEM) Trading 5.3% Higher marketbeat.com - April 1 at 5:51 PMCullinan Oncology, Inc. (NASDAQ:CGEM) Sees Significant Increase in Short Interestmarketbeat.com - March 29 at 7:52 PMCullinan Oncology (NASDAQ:CGEM) Earns "Buy" Rating from HC Wainwrightmarketbeat.com - March 18 at 5:11 PMCullinan Oncology, Inc. Expected to Post Q2 2024 Earnings of ($0.98) Per Share (NASDAQ:CGEM)marketbeat.com - March 18 at 1:59 AMCullinan Oncology Inc (CGEM) Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - March 16 at 8:38 AMCullinan Oncology (NASDAQ:CGEM) Shares Down 3.2% marketbeat.com - March 15 at 12:59 PMHere's Why We're Not Too Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Situationfinance.yahoo.com - March 15 at 10:45 AMCGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023investorplace.com - March 14 at 1:03 PMCullinan Oncology, Inc.: Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 14 at 12:50 PMCullinan Oncology: Q4 Earnings Insightsbenzinga.com - March 14 at 12:50 PM Get Cullinan Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here CGEM Media Mentions By Week CGEM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEM News Sentiment▼0.010.36▲Average Medical News Sentiment CGEM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEM Articles This Week▼62▲CGEM Articles Average Week Get Cullinan Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VIR News SRRK News FDMT News TARS News BCRX News AUTL News XNCR News MGNX News NMRA News ADMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
